ESSA Pharma (EPIX)

• Market cap: $71.5M
• 1 day: -1.23%
• 5 days: -3.01%
• 1 month: -10.56%
• 3 months: -73.86%
• 6 months: -66.80%
• Year to date: -75.04%
• 1 year: -78.10%
• 5 years: -70.73%
• 10 years: -99.15%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

Employees: 35

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

3% more funds holding

Funds holding: 31 [Q2] → 32 (+1) [Q3]

3% more capital invested

Capital invested by funds: $207M [Q2] → $213M (+$5.65M) [Q3]

9.67% less ownership

Funds ownership: 88.79% [Q2] → 79.11% (-9.67%) [Q3]

46% less call options, than puts

Call options by funds: $120K | Put options by funds: $224K

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $2 24% upside
• Avg. target: $2 24% upside
• High target: $2 24% upside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

Piper Sandler Joseph Catanzaro 32% 1-year accuracy 10 / 31 met price target

24% upside $2

Neutral Downgraded

4 Nov 2024